National Eye Institute Considers Exclusive Patent License for Age-Related Macular Degeneration Treatment

Summary

The National Eye Institute, part of the National Institutes of Health, is considering granting an exclusive patent license to CellRay, LLC, for a potential treatment of age-related macular degeneration using manufactured retinal pigment epithelium cells.